Search Results 201-210 of 8426 for Terminal
... terminal half-life of luspatercept based on multiple-dose pharmacokinetics [PK] data) after discontinuation of study therapy. Male subjects must: Practice ...
This complication of radiation therapy for cancer can cause stomach pain, vomiting or diarrhea. For most people, symptoms go away within weeks.
Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.
German centers only: Treatment with any known non-marketed drug substance or experimental therapy within 5 terminal half lives or 4 weeks prior to ...
Terminal illness (other than HF) with expected survival of less than 1 year. Pregnancy or breastfeeding mothers. Eligibility last updated 4/28/22. Questions ...
* Known allergies to any of the components of the compression. * Terminal illness or current cancer therapy with chemotherapy * Inability to undergo ongoing ...
Have serious accompanying health problems associated with terminal (e.g., lysosomal storage diseases) or neurodegenerative diseases (e.g., muscular dystrophy).
Participation eligibility · Crohn's disease patients with involvement of terminal ileum (thickness > 3mm) or other segments of small or large bowel · Aage above ...
Elevated N-terminal pro-brain natriuretic peptide (NT-proBNP) at Visit 1, analysed at the central laboratory 6. Treated according to best possible standard ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.